The AstraZeneca group is singled out for not meeting its vaccine delivery targets to Europe.
The Twenty-Seven were expecting nearly 40 million doses this quarter, but according to information from Europe 1, only 30 million doses could finally be received.
Anger is mounting in Paris as in Brussels, against the AstraZeneca group.
The latter was initially supposed to provide more than 100 million vaccines against Covid-19 to Europe but they are still pending.
"AstraZeneca is making efforts but not everything possible", tweeted Thursday Thierry Breton, European Commissioner.
If this continues, the goals for the first quarter will not be met, he continues.
If deliveries have already been reduced, the 27 of the European Union still expect 40 million doses this quarter.
According to information from Europe 1, only 30 million doses would ultimately be received.
>> LIVE -
Coronavirus: follow the evolution of the situation Friday March 12
And the decline in vaccine deliveries could continue in the second quarter.
"AstraZeneca must respect its commitments and present us with a precise action plan", has already reacted the Minister of Industry, Agnès Pannier Runacher.
"Europe will defend its interests," promises for his part the Secretary of State for European Affairs, Clément Beaune.
Low production in Belgium, international import restriction
The AstraZeneca group is struggling to meet the deadlines for several reasons.
First, its first problems came from its Belgian factory: to compensate for a lower production than expected, the company planned to import doses from its sites in the rest of the world.
>>
Find the morning show of the day in replay and podcast here
But now, it is its factories abroad that are blocking.
London in particular obtained that the British factories of the group run only for the English.
The same goes for India or the United States, which restrict exports, said the person in charge of vaccination in Sweden.
The vaccine called into question
The official explanations are long overdue, while the AstraZeneca vaccine is in turmoil.
Denmark, Iceland and Norway have suspended injections of the British serum, over fears of blood clots in vaccinated people, and Italy has banned the use of a batch.
>> READ ALSO -
What do we know about the Johnson & Johnson single dose vaccine?
The European Medicines Agency assures that the vaccine is safe: "There is currently no indication that the vaccination caused these conditions which are not listed as side effects of this vaccine.